Literature DB >> 7297566

Cytochrome P-450 monooxygenase activities in human and rat liver microsomes.

P Kremers, P Beaune, T Cresteil, J de Graeve, S Columelli, J P Leroux, J E Gielen.   

Abstract

Microsomes were prepared from human livers obtained from renal donors of various ages and both sexes. Their drug-metabolizing capacity was measured and compared to that of rat liver microsomes. The following parameters were investigated: cytochrome P-450, cytochrome B5, NADPH-cytochrome c reductase, epoxide hydrolase, aryl hydrocarbon hydroxylase, benzphetamine N-demethylase, p-nitroanisole-O-demethylase, ethoxycoumarin-O-deethylase, steroid-16 alpha-hydroxylase. In addition, the metabolism of benzo(a)pyrene, progesterone, pregnenolone, testosterone, dehydroepiandrosterone and estradiol was studied in detail in vitro. The inhibitory effect of metyrapone and alpha-naphthoflavone on 7-ethoxycoumarin-O-deethylase was measured. The microsomal proteins of both species were separated by polyacrylamide gel electrophoresis in the presence of dodecyl sulfate. The following conclusions were drawn from the results obtained. Human liver microsomes can be stored under optimal conditions for the measurement of a large variety of enzymic activities. Human liver microsomes are able to metabolize the various xenobiotics used as substrates with a rate similar to that of female rat liver microsomes. No sex-linked difference in enzymic activity was observed in human microsomes. Significant differences in benzo(a)pyrene and steroid metabolism were registered when human and rat liver microsomes were compared. The monooxygenase activities, the sensitivity to in vitro alpha-naphthoflavone and metyrapone, the results of steroid metabolism, and slab gel electrophoresis are strong indications for multiplicity of human liver cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297566     DOI: 10.1111/j.1432-1033.1981.tb05561.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  20 in total

1.  Molecular imaging of σ receptors: synthesis and evaluation of the potent σ1 selective radioligand [18F]fluspidine.

Authors:  Steffen Fischer; Christian Wiese; Eva Grosse Maestrup; Achim Hiller; Winnie Deuther-Conrad; Matthias Scheunemann; Dirk Schepmann; Jörg Steinbach; Bernhard Wünsch; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-12       Impact factor: 9.236

2.  Nucleic acid binding and intracellular localization of unr, a protein with five cold shock domains.

Authors:  H Jacquemin-Sablon; G Triqueneaux; S Deschamps; M le Maire; J Doniger; F Dautry
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

3.  A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.

Authors:  D Sesardic; A R Boobis; R J Edwards; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

4.  Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450.

Authors:  T Cresteil; C Célier; P Kremers; J P Flinois; P Beaune; J P Leroux
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

5.  The stimulatory effects of asbestos on NADPH-dependent lipid peroxidation in rat liver microsomes.

Authors:  M Fontecave; D Mansuy; M Jaouen; H Pezerat
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

6.  Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

Authors:  M Bourdi; D Larrey; J Nataf; J Bernuau; D Pessayre; M Iwasaki; F P Guengerich; P H Beaune
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 7.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

8.  The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

Authors:  H S Purba; J L Maggs; M L Orme; D J Back; B K Park
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

9.  Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.

Authors:  R Seelig; M Renz; G Bünger; H Schröter; H P Seelig
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

10.  Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38.

Authors:  L Massaad; G G Chabot; C Toussaint; S Koscielny; J Morizet; M C Bissery; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.